SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-037535
Filing Date
2024-02-15
Accepted
2024-02-15 16:06:36
Documents
14
Period of Report
2024-02-15
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K d769876d8k.htm   iXBRL 8-K 27399
  Complete submission text file 0001193125-24-037535.txt   150626

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20240215.xsd EX-101.SCH 2847
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20240215_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20240215_pre.xml EX-101.PRE 11259
15 EXTRACTED XBRL INSTANCE DOCUMENT d769876d8k_htm.xml XML 3620
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 24643821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)